These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6089313)
21. The measurement of angiotensin-converting enzyme in subjects receiving captopril. Roulston JE; MacGregor GA N Engl J Med; 1980 Aug; 303(7):397. PubMed ID: 6248782 [No Abstract] [Full Text] [Related]
22. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril. Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930 [TBL] [Abstract][Full Text] [Related]
23. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme. Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812 [TBL] [Abstract][Full Text] [Related]
24. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis. Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438 [TBL] [Abstract][Full Text] [Related]
25. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits. Chen X; Pitt BR; Moalli R; Gillis CN J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968 [TBL] [Abstract][Full Text] [Related]
26. In vitro stability of the inhibition of serum converting enzyme by fosinopril. Grima M; Barthelmebs M; Stephan D; Welsch M; Imbs JL Fundam Clin Pharmacol; 1992; 6(2):83-8. PubMed ID: 1318861 [TBL] [Abstract][Full Text] [Related]
27. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. Shalaby SM; Zakora M; Otte J J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177 [TBL] [Abstract][Full Text] [Related]
28. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney. Hiwada K; Inoue Y; Kokubu T Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril. Udupa EG; Rao NM Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434 [TBL] [Abstract][Full Text] [Related]
30. Alteration of the granulomatous response in murine schistosomiasis by the chronic administration of captopril, an inhibitor of angiotensin-converting enzyme. Weinstock JV; Boros DL Gastroenterology; 1981 Nov; 81(5):953-8. PubMed ID: 6269948 [TBL] [Abstract][Full Text] [Related]
31. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin-I converting enzyme activity in the sera of captopril-treated hypertensive patients. Rosenthal T; Holtzman E; Yaron A Clin Exp Hypertens A; 1982; 4(3):367-77. PubMed ID: 6280902 [TBL] [Abstract][Full Text] [Related]
34. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
35. Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration. Bhuyan BJ; Mugesh G Org Biomol Chem; 2011 Jul; 9(14):5185-92. PubMed ID: 21629912 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding. Jackson B; Cubela R; Johnston CI Aust J Exp Biol Med Sci; 1986 Apr; 64 ( Pt 2)():149-55. PubMed ID: 3017276 [TBL] [Abstract][Full Text] [Related]
37. Kinetics of captopril- and enalapril-induced inhibition of pulmonary angiotensin converting enzyme in vivo. Moalli R; Howell RE; Gillis CN J Pharmacol Exp Ther; 1985 Aug; 234(2):372-7. PubMed ID: 2991497 [TBL] [Abstract][Full Text] [Related]
38. Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat. Johnston CI; Cubela R; Jackson B Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):123-9. PubMed ID: 2856050 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers. Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965 [TBL] [Abstract][Full Text] [Related]
40. [Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation]. Zhang XH; Ma XJ; Luo J; Shao JH; Geng QX; Zhu XL; Tang YS; Xu FY Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):592-5. PubMed ID: 15144597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]